Gout Study - H2357 Clinical Trial Information

Novartis Clinical Trials and Medical Research Studies Recruiting in the U.S.

Mailing List


	Sign up and receive information about Novartis clinical trials in your health-related areas of interest. For U.S. residents only.

Novartis Clinical Trials provides information about research studies recruiting within the U.S. Visit ClinicalTrials.gov, a registry of federally and privately supported clinical trial for more information regarding clinical trials outside of the U.S.

Study Description

Screening

Study Centers

Contact/Consent

Gout Study - H2357

The purpose of this randomized, controlled study is to evaluate the efficacy of a Novartis investigative drug in relieving pain from the acute gout flare and preventing recurrence of new gout flares, in sufferers that are either intolerant or non-responsive to traditional non-steroidal anti-inflammatory drugs (NSAIDs) and/or colchicine treatments. An investigational drug is a drug that is being tested and is not approved for sale in the United States by the Food and Drug Administration (FDA).
Trial phase: Phase 3
Participation Duration: Participants will be required to visit the study center 7 times over a 3 month period. Three additional visits will be required for each acute gout flare up..
Protocol Number: CACZ885H2357

The next step is to see if you (or the participant) meet the basic criteria required for participation in this clinical trial. Please fill out the questionnaire below to see if you (or the participant) may be suitable for the clinical trial. Your answers to these questions are not retained by this system. You must answer the questions below for yourself, or, you must be the legally authorized representative of the potential participant in order to answer the questions on their behalf. If you (or the participant) do not meet the preliminary qualifications, you may search for other clinical trials of interest or sign up to the Mailing List.

Answers to all questions are required to determine if you meet the preliminary qualifications for the study.

1) Participation in a clinical trial will require travel to a study center where the clinical trial is being conducted. How far would you (or the participant) be willing to travel to a study center to participate in this clinical trial? Please note that participation in these clinical trials may require a number of visits to the study center and travel expenses may not be covered.

25 miles 50 miles 100 miles 150 miles Unlimited

2) Please enter your residential postal zip code.

3) Are you ≥ 18 and ≤85 years of age?
Yes
No

4) Have you had at least 3 gout flares within the last 12 months?
Yes
No

5) Are you intolerant of NSAIDs and/or colchicines?
Yes
No

6) Have you ever had any cancer, other than precancerous skin conditions within the past 5 years?
Yes
No

7) Have you had or do you currently have tuberculosis (TB)?
Yes
No

8) Do you suffer from unstable arrhythmia, rheumatoid arthritis, severe coronary artery disease, or congestive heart failure?
Yes
No

9) Are you pregnant or nursing?
Yes
No

	Site Map \| Contact Us \| Find a Clinical Trial \| Mailing List \| Clinical Trial FAQs
	Clinical Trials Glossary \| About Informed Consent \| Medical Research Areas
	Clinical Trial Resources \| How to use this website